yext-knowledge-tags-location-id=
Treatments For Psoriasis May Offer Effective Results | Water's Edge

 New Treatments May Offer Effective Results For Patients With Psoriasis

New Treatments May Offer Effective Results For Patients With Psoriasis

When it comes to common skin conditions, people are likely to think of acne or skin cancer, two problems often treated by dermatology and skin cancer specialists. But while around 40% of teenagers will develop acne, and more than 2 million people are diagnosed with nonmelanomic skin cancer every year, another popular skin condition deserves attention: psoriasis.

There are a number of different types of psoriasis, but the disease is typically distinguished by red, irritated patches on the skin and nails. In at least one form of the disorder, it can be difficult to tell the difference between psoriasis and seborrheic dermatitis, another irritating skin condition which targets the scalp and ears. Fortunately, once the disease is diagnosed, dermatologists can utilize a number of topical treatments, pills or injections, and light therapies to treat the irritation and skin patches. Biologic medications may even be used to treat severe or disabling cases. And therapies continue to improve and innovate: recently, a Swiss pharmaceutical company announced that one of their products has been shown to be effective at treating moderate to severe psoriasis.

Novartis, a multinational company based in Switzerland, recently presented their study on a product called secukinumab to the European Association of Dermatology and Venereology Congress in the Netherlands. Secukinumab is designed to treat plaque psoriasis, the most common form of the disorder, which features inflamed, scaly, red skin. Currently, the treatment is being touted as an effective way to improve psoriasis symptoms, improving and preventing joint damage, and importantly showing no negative impacts on patient health. And while this product likely won’t be available to dermatologist clinics and doctors for some time, Novartis’s recent presentation is only the most recent step towards having the medication accepted as a treatment: previously, the company submitted secukinumab to regulatory organizations in both the United States and Europe.

Due to the discomfort, joint damage, and unappealing appearance of the many different types of psoriasis, getting proper treatment is typically very important to patients who want to live life comfortably and without undue anxiety. While treatments like secukinumab are still being tested for their effectiveness and safety, there are a variety of other treatment options which can be prescribed by a dermatologist. If you or a loved one is suffering from the effects of psoriasis, schedule an appointment at a dermatologist clinic today to discuss how best to treat this common skin condition.